Market Place
Sourcing Support
Moderna Claims Early Victory For Cancer Antigen In Melanoma
13 Oct 2025 //
BIOSPACE
Merck Nears $10 Billion Deal for Respiratory Drugmaker Verona
10 Jul 2025 //
PRESS RELEASE
BMS, Merck, Amgen & more face near-term generic woes: Leerink
13 Nov 2024 //
FIERCE PHARMA
Merck stops testing combo drug for skin cancer as more patients discontinue
14 May 2024 //
REUTERS
Bangladesh`s Beximco to sell generic
08 Nov 2021 //
REUTERS
Mylan Loses Tribunal Challenge to Merck Diabetes Treatment Patent
11 May 2021 //
BLOOMBERGLAW
With latest Keytruda approval, Merck beats Bristol Myers to immunotherapy target
18 Jun 2020 //
BIOPHA RMADIVE
FDA Requires Boxed Warning for Singulair, Generics
05 Mar 2020 //
RAPS
MSN labs to launch two new generics in USA
06 Sep 2019 //
THEPHARMALETTER
Merck Announces First-Quarter 2019 Financial Results
30 Apr 2019 //
BUSINESSWIRE
Janumet (metformin hydrochloride; sitagliptin phosphate): Merck vs. Sandoz
15 Feb 2019 //
PATENT LITIGATION
Janumet (metformin hydrochloride; sitagliptin phosphate) : Merck vs. Mylan
14 Feb 2019 //
PATENT LITIGATION
Janumet XR (metformin HCl; sitagliptin phosphate) : Merck vs. Alvogen PB
13 Feb 2019 //
PATENT LITIGATION
Janumet XR (metformin HCl; sitagliptin phosphate) : Merck v. Anchen Pharm
13 Feb 2019 //
PATENT LITIGATION
Janumet (metformin hydrochloride; sitagliptin phosphate) : Merck v. Apotex
13 Feb 2019 //
PATENT LITIGATION
Janumet (metformin HCl; sitagliptin phosphate) : Merck v. Macleods Pharma
13 Feb 2019 //
PATENT LITIGATION
Merck loses bid to revive $200 million Gilead verdict at U.S. high court
08 Jan 2019 //
REUTERS
Mylan says patent office cancels Sanofi`s Lantus patents
14 Dec 2018 //
REUTERS
Mylan says patent office cancels Sanofi`s Lantus patents
14 Dec 2018 //
REUTERS
Pomalyst (Pomalidomide): Celgene Corporation vs. Apotex
24 Nov 2018 //
PATENT LITIGATION
Merck asks SCOTUS for its $200M in Gilead patent dues
26 Sep 2018 //
FIERCE PHARMA
Express Scripts bars 48 drugs for 2019, hitting AbbVie, Gilead, Boehringer
08 Aug 2018 //
FIERCE PHARMA
Lawyers Compete To Represent Zetia Buyers In Antitrust Case
30 Jul 2018 //
LAW360
Drug patent protection regime needs to change
27 Jul 2018 //
IRISH TIMES
GSK, J&J CEOs invited to dinner during Trump U.K. visit: FT
05 Jul 2018 //
FIERCE PHARMA
Noxafil (Posaconazole): Merck Sharp & Dohme Corp. v. Mylan Laboratories
23 Mar 2018 //
PATENT LITIGATION
Reckless vs. Negligent: Court Says Merck can be Sued Over Generic Drug Labels
20 Mar 2018 //
RAPS
Kenneth Frazier, Merck CEO who stood up to Trump, breaks his silence
20 Feb 2018 //
THEGLOBE
Noxafil® (Posaconazole): Merck Sharp & Dohme v. Fresenius Kabi USA
02 Feb 2018 //
PATENT LITIGATION
Merck, Glenmark Stifled Cholesterol Drug Market, Suit Says
17 Jan 2018 //
LAW360
Emend®(Fosaprepitant Dimeglumine): Merck Sharp & Dohme Corp. V. MSN Laboratories
16 Jan 2018 //
PATENT LITIGATION
In Supreme Court petition, Merck argues that FDA power shields against liability
07 Dec 2017 //
FIERCE PHARMA
Dulera® (Pemetrexed Disodium): Aptar Group & Aptar France.,V.3m Co., Merck & Co
30 Aug 2017 //
PATENT LITIGATION
Sun Pharma shares soar on US FDA approval for generic Merck’s cholesterol drug
12 Jun 2017 //
FINANCIALEXPRESS
Merck`s Vytorin set for massive sales slide as generics hit
28 Apr 2017 //
FIERCE PHARMA
Glenmark & Evestra, Inc. Announce Partnership Agreement for Generic NuvaRing
02 Mar 2017 //
PR NEWSWIRE
Generics set to undercut blockbusters from Merck, Novartis and Bristol-Myers
18 Jan 2017 //
FIERCE PHARMA
Pharma companies increase investments for global biosimilar push
24 Oct 2016 //
BUSINESS STANDARD
Piramal Bulks up in Injectable Generics, Buying Five Drugs from J&J
12 Oct 2016 //
FIERCE PHARMA
Granules to market Par Pharma`s generic heartburn drug in the US
21 Jan 2016 //
BUSINESS STANDARD
Ajanta Pharma launches generic asthma drug in US market
16 Nov 2015 //
ECONOMIC TIMES
Allergan confirms patent challenge for generic Noxafil
13 Aug 2015 //
PBR
Merck eyes opportunity for omarigliptin filing with Japan`s PMDA
03 Aug 2015 //
FIERCE PHARMA ASIA
Pfizer Quits Over-the-Counter Lipitor Program After Trial Fails
30 Jul 2015 //
BLOOMBERG BUSINESS
Two big problems with generic-drug substitution
23 Jun 2015 //
CNBC
Celltrion Seeks FDA Approval for Biosimilar Remsima
01 Apr 2015 //
FIRST WORLD PHARMA
Delhi High Court Bars Glenmark From Selling Two Anti-Diabetes Drugs
23 Mar 2015 //
BUSINESS TODAY
